Dosidal · Switzerland

AREXVY, Pulver und Suspension zur Herstellung einer Injektionssuspension

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:69310 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 69310
atc: J07BX05
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2024-05-02
term: zugelassen
valid_until: 2029-05-01
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: J07BX05
authorisation_number: 69310
form: PULSIN
holder: GlaxoSmithKline AG
holder_partner_nr: 1000930
it_number: 08.08.
name: AREXVY, Pulver und Suspension zur Herstellung einer Injektionssuspension
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
O3Roiy9DOm5Oxb0mia3a98EqgRRhkThotJY3Li5x_Xq-l9gpYd-6-DZXz5UKZAQzcC9q8uKr96i4ys6cqFaP7Q
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal